• FLUSPIRILENE CHEMBL46516 FDA Approved

    Alternate Names:

    Fluspirilene
    Redeptin
    MCN-JR-6218
    R-6218
    Imap
    AC1L1FUB
    C29H31F2N3O
    EU-0100518
    LOPAC-F-100
    BRN 0633853
    CID3396
    5-26-04-00097 (BEILSTEIN HANDBOOK REFERENCE)
    MLS000069357
    IMAP (TN)
    8-[4,4-BIS(4-FLUOROPHENYL)BUTYL]-1-PHENYL-1,3,8-TRIAZASPIRO[4.5]DECAN-4-ONE
    DB04842
    EINECS 217-418-6
    NCGC00093913-02
    PRESTWICK1_000906
    MLS001333730
    BSPBIO_001343
    NCGC00093913-03
    BIO-0707
    HMS1570F14
    FLUSPIRILENUM [INN-LATIN]
    F100_SIGMA
    NCGC00093913-01
    MOLPORT-002-540-769
    1841-19-6
    D02629
    FLUSPIRILENE [USAN:INN:BAN]
    NCGC00016595-01
    8-[4,4-BIS (P-FLUOROPHENYL)BUTYL]- 1-PHENYL-1,3,8-TRIAZINO[4,5]DECAN-4-ONE
    F-100
    FLUSPIRILENUM
    1-PHENYL-4-OXO-8-(4,4-BIS(4-FLUOROPHENYL)BUTYL)-1,3,8-TRIAZASPIRO(4,5)DECANE
    SPIRODIFLAMINE
    HMS2089C15
    AB00513956
    FLUSPIRILEN
    PRESTWICK2_000906
    CAS-1841-19-6
    SPBIO_002951
    FLUSPIRILENO
    HMS1989D05
    PRESTWICK3_000906
    BSPBIO_000752
    PRESTWICK0_000906
    8-[4,4-BIS(P-FLUOROPHENYL)BUTYL]-1-PHENYL-1,3,8-TRIAZINO[4.5]DECAN-4-ONE
    R 6218
    NCGC00093913-05
    SPIROPIPERIDINE ANALOGUE, 1
    1,3,8-TRIAZASPIRO[4.5]DECAN-4-ONE, 8-[4,4-BIS(4-FLUOROPHENYL)BUTYL]-1-PHENYL-
    1,3,8-TRIAZASPIRO(4.5)DECAN-4-ONE, 8-(4,4-BIS(P-FLUOROPHENYL)BUTYL)-1-PHENYL-
    OPREA1_804941
    8-(4,4-BIS(P-FLUOROPHENYL)BUTYL)-1-PHENYL-1,3,8-TRIAZASPIRO-(4.5)DECAN-4-ONE
    L001195
    159093
    NCGC00015424-01
    R6218
    NCGC00093913-04
    SMR000058304
    LOPAC0_000518
    HMS1791D05
    BRD-K77947974-001-04-9
    FLUSPIRILENO [INN-SPANISH]
    DAP000980
    3396
    NCGC00015424-08
    BPBIO1_000828
    FLUSPIRILENE (USAN/INN)
    NCGC00015424-02
    8-[4,4-BIS(4-FLUOROPHENYL)BUTYL]-4-PHENYL-2,4,8-TRIAZASPIRO[4.5]DECAN-1-ONE
    LS-154759
    1,3,8-TRIAZASPIRO(4.5)DECAN-4-ONE, 8-(4,4-BIS(4-FLUOROPHENYL)BUTYL)-1-PHENYL-
    lmap
    Imap Inj 2mg/ml
    Imap Forte Inj 10mg/ml
    8-[4,4-BIS (P-FLUOROPHENYL)BUTYL]-1-PHENYL-1,3,8-TRIAZINO[4,5]DECAN-4-ONE
    8-(4,4-BIS(P-FLUOROPHENYL)BUTYL)-1-PHENYL-1,3,8-TRIAZASPIRO(4,5)DECAN-4-ONE
    3B1-002459
    AB00513956-10
    FT-0668770
    HE320216
    HE069798
    NCGC00015424-09
    NCGC00015424-07
    NCGC00015424-06
    NCGC00015424-05
    NCGC00015424-03
    LP00518
    TOX21_110142_1
    AKOS015969747
    TOX21_110142
    AOB33780
    ZINC537755
    HMS3402D05
    HMS3372H20
    HMS3261H17
    HMS2233B20
    HMS2097F14
    QOYHHIBFXOOADH-UHFFFAOYSA-N
    CTK7B9885
    BDBM26948
    MCN-JR 6218
    SCHEMBL42082
    CID_3396
    GTPL85
    C5QA4GLR9M
    1,3,8-TRIAZASPIRO[4.5]DECAN-4-ONE, 8-[4,4-BIS(P-FLUOROPHENYL)BUTYL]-1-PHENYL-
    IMAPREG
    REDEPTINREG
    FLUSPIRILINE
    DSSTOX_GSID_45152
    DSSTOX_RID_80706
    DSSTOX_CID_25152
    NCGC00015424-11
    NCGC00015424-04
    CCG-204608
    UNII-C5QA4GLR9M
    135650278
    85

    Drug Info:

    Drug Class antipsychotic agents
    Year of Approval approved before 1982
    FDA Approval Approved before 1982
    Drug Class small molecule
    Drug Indications Antipsychotic Agents
    Drug Categories tranquilizing agents
    Drug Categories therapeutic uses
    Drug Categories spiro compounds
    Drug Categories psychotropic drugs
    Drug Categories psycholeptics
    Drug Categories polycyclic compounds
    Drug Categories piperidines
    Drug Categories physiological effects of drugs
    Drug Categories pharmacologic actions
    Drug Categories organic chemicals
    Drug Categories neurotransmitter agents
    Drug Categories nervous system
    Drug Categories molecular mechanisms of pharmacological action
    Drug Categories imidazoles
    Drug Categories hydrocarbons, cyclic
    Drug Categories hydrocarbons
    Drug Categories heterocyclic compounds, 1-ring
    Drug Categories heterocyclic compounds
    Drug Categories dopamine antagonists
    Drug Categories dopamine agents
    Drug Categories diphenylbutylpiperidine derivatives
    Drug Categories chemical actions and uses
    Drug Categories central nervous system depressants
    Drug Categories central nervous system agents
    Drug Categories azoles
    Drug Categories antipsychotic agents
    Drug Groups approved
    Drug Type small molecule
    (2 More Sources)